| Trial ID: | L3164 |
| Source ID: | NCT05822674
|
| Associated Drug: |
Sitagliptin/Metformin ( 50/500mg) Oral Tablet
|
| Title: |
Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin/metformin ( 50/500mg) Oral Tablet|DRUG: Empagliflozin/metformin(10/500mg) Oral Tablet
|
| Outcome Measures: |
Primary: Stress hyperglycemia Ratio, The ratio of stress-to-on admission blood glucose was calculated, 10 week | Secondary: Hematological indices, Concentration of hemoglobin (g/dL) and the value of mean corpuscular volume (fL), 10 week|Inflammatory markers, Concentration of c-reactive protein (mg/L), 10 week
|
| Sponsor/Collaborators: |
Sponsor: University of Diyala
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
80
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2022-01-01
|
| Completion Date: |
2023-02-01
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-21
|
| Locations: |
College of Medicine, University of Diyala, Baqubah, Diyala, 32001, Iraq
|
| URL: |
https://clinicaltrials.gov/show/NCT05822674
|
